A password will be e-mailed to you.

Visit the Cresco Labs Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. CHICAGO, April 26, 2019–(BUSINESS WIRE)– Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has filed and received a receipt for a preliminary short form base shelf prospectus (the “Shelf Prospectus”) with the securities commissions in each of the provinces of Canada, except Québec. Although we have no immediate plans to raise capital through this shelf filing, we believe it’s prudent to give the Company the flexibility to access capital in the future when opportunities emerge to continue executing on our growth strategies. We have consistently demonstrated strong capital stewardship and we expect to continue driving shareholder value through our capital deployment. The Shelf Prospectus, when made final, will allow the Company to offer up to C$500,000,000 of subordinate voting shares, debt securities, subscription receipts, warrants, and units, or any combination thereof, from time to time during the 25-month period that the (final) Shelf Prospectus is effective. Cresco Labs Files $500 Million Preliminary Base Shelf Prospectus

thumbnail courtesy of newcannabisventures.com